FIM
CKPT

Freedom Investment Management’s Checkpoint Therapeutics CKPT Stock Holding History

Freedom Investment Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,791
Closed -$18.6K – 721
2022
Q3 		$18.6K Sell
1,791
-70
-4% -$834 ﹤0.01% 715
2022
Q2 		$19.2K Sell
1,861
-25
-1% -$327 ﹤0.01% 723
2022
Q1 		$33K Buy
+1,886
New +$40.5K ﹤0.01% 763

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Freedom Investment Management's CKPT Position: Q4 2022 in Review

Freedom Investment Management sold out of Checkpoint Therapeutics (CKPT) in Q4 2022, closing a stake of 1,791 shares — an estimated $18.6K sold.

Freedom Investment Management first reported a position in CKPT in Q1 2022 and held it in 3 quarters. The position peaked at $33K in Q1 2022. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Freedom Investment Management reported no remaining Checkpoint Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Freedom Investment Management sold 1,791 Checkpoint Therapeutics shares in Q4 2022, an estimated $18.6K.
  • Freedom Investment Management first reported a position in Checkpoint Therapeutics in Q1 2022 and held it in 3 quarters.
  • Freedom Investment Management's Checkpoint Therapeutics position peaked at $33K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Freedom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.